Cargando…

Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors

The present study was undertaken to further characterize the interaction of monoclonal antibodies (mAbs) against tumor necrosis factor (TNF) receptors with different targets, and to assess their ability to influence TNF effects on U937 and human endothelial cell (HEC) functions. Actions of recombina...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1990
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188665/ https://www.ncbi.nlm.nih.gov/pubmed/2172437

Ejemplares similares

Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
Publicado: (1990)

Development of monoclonal antibodies for quantification of bovine tumor necrosis factor-α
por: Sipka, Anja, et al.
Publicado: (2021)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha
por: Liao, Xinmei, et al.
Publicado: (2021)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
por: Lang, Isabell, et al.
Publicado: (2018)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014)

Development of specific monoclonal antibodies for the detection of natural chicken tumor necrosis factor-alpha
por: Yang, Yi, et al.
Publicado: (2022)

Systemic administration of an anti-tumor necrosis factor-alpha monoclonal antibody protects against endotoxin-induced uveitis in rats
por: Ge, Qingman, et al.
Publicado: (2016)

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
por: Ceran, Ceyhan, et al.
Publicado: (2012)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
por: Gulli, Salvatore, et al.
Publicado: (2003)

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
Publicado: (1989)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus monoclonal antibody
por: Kouno, Michiyoshi, et al.
Publicado: (2013)

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation
por: Kirkham, Bruce W, et al.
Publicado: (2014)

The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies
por: Chan, Conrad En-Zuo, et al.
Publicado: (2022)

Production of Monoclonal Antibody against Human Nestin
por: Hadavi, Reza, et al.
Publicado: (2010)

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75
Publicado: (1995)

Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort
por: Khoury, Gisèle, et al.
Publicado: (2020)

Characterization of the binding properties and retrograde axonal transport of a monoclonal antibody directed against the rat nerve growth factor receptor
Publicado: (1985)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model
por: Takasago, Takeshi, et al.
Publicado: (2023)

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
por: Rowlinson-Busza, G., et al.
Publicado: (1995)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
por: Ben-Aissa, H., et al.
Publicado: (1985)

A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes
por: Charnesky, Andrew J., et al.
Publicado: (2023)

Functional analysis of the receptor binding domain of SARS coronavirus S1 region and its monoclonal antibody
por: Kim, Hyun, et al.
Publicado: (2014)

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120
por: Binley, James M, et al.
Publicado: (2007)

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120
por: Binley, James M, et al.
Publicado: (2006)

Molecular and cellular basis for immunomodulation with monoclonal antibodies
por: Melero, Ignacio
Publicado: (2015)

Structural basis for cooperativity of human monoclonal antibodies to meningococcal factor H-binding protein
por: Peschiera, Ilaria, et al.
Publicado: (2019)

Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus
por: Jin, Jing, et al.
Publicado: (2019)

Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
por: Kim, Ji Woong, et al.
Publicado: (2022)

Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodies.
por: Gore, M. E., et al.
Publicado: (1983)

Human Monoclonal Antibodies Against HIV and Emerging Viruses
por: Dimitrov, Dimiter S.
Publicado: (2008)

Shedding of tumor necrosis factor receptors by activated human neutrophils
Publicado: (1990)

Monoclonal antibodies directed against the sexual binding site of Chlamydomonas eugametos gametes
Publicado: (1988)

Monoclonal Antibodies to the Thyrotropin Receptor
por: Ando, Takao, et al.
Publicado: (2005)

Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
por: Doyle, Michael P., et al.
Publicado: (2021)

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.
por: Okamoto, S., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_ufsbrl7tf071mokj6k4j3o6nku